New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 1, 2013
06:27 EDTINFIInfinity Pharmaceuticals assumed with an Overweight at Piper Jaffray
Target $53.
News For INFI From The Last 14 Days
Check below for free stories on INFI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
09:26 EDTINFIInfinity Pharmaceuticals management to meet with JMP Securities
Subscribe for More Information
September 4, 2014
10:29 EDTINFIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AeroVironment (AVAV) upgraded to Buy from Hold at Benchmark Co... D.R. Horton (DHI) upgraded to Buy from Neutral at UBS... IAC (IACI) upgraded to Overweight from Equal Weight at Barclays... Imperial Tobacco (ITYBY) upgraded to Outperform from Underperform at Exane BNP Paribas... Infinity Pharmaceuticals (INFI) upgraded at JMP Securities.
08:52 EDTINFIInfinity Pharmaceuticals upgraded at JMP Securities
Subscribe for More Information
07:38 EDTINFIInfinity Pharmaceuticals price target raised to $21-$25 from $17-$20 at Wells Fargo
Wells Fargo increased its price target on Infinity (INFY) after the company announced a global development and commercialization oncology agreement with AbbVie (ABBV) for duvelisib. The firm thinks the financial terms of the deal are favorably for Infinity, and significantly lower the risk presented by Infinity's stock. It raised its estimate of the drug's chances of success to 75% from 65% and keeps an Outperform rating on Infinity.
07:17 EDTINFIInfinity deal terms suggest intention to stay independent, says Jefferies
Subscribe for More Information
06:13 EDTINFIInfinity upgraded to Outperform from Market Perform at JMP Securities
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use